Viral Entry and NS1 as Potential Antiviral Drug Targets

Adv Exp Med Biol. 2018:1062:107-113. doi: 10.1007/978-981-10-8727-1_8.

Abstract

A general discussion on viral entry and NS1 as potential drug targets was held at the Tofo Advanced Study Week (TASW) on Emerging Viral Diseases in September 2016. The opportunities and gaps for developing therapeutic countermeasures, to take advantage of the high-resolution cryo-electron microscopy structures of dengue and Zika viruses as well as the novel features of NS1 revealed by the 3D structures, were deliberated.

Keywords: Entry inhibitors; Flavivirus entry mechanism; NS1 delipidation; NS1 pathogenicity; Therapeutic antibodies.

Publication types

  • Review

MeSH terms

  • Animals
  • Antiviral Agents / pharmacology*
  • Dengue / virology*
  • Dengue Virus / chemistry
  • Dengue Virus / genetics
  • Dengue Virus / physiology*
  • Humans
  • Viral Nonstructural Proteins / antagonists & inhibitors
  • Viral Nonstructural Proteins / chemistry
  • Viral Nonstructural Proteins / genetics
  • Viral Nonstructural Proteins / metabolism*
  • Virus Internalization / drug effects*
  • Zika Virus / chemistry
  • Zika Virus / genetics
  • Zika Virus / physiology*
  • Zika Virus Infection / virology*

Substances

  • Antiviral Agents
  • Viral Nonstructural Proteins